Literature DB >> 26055673

Sleep in Schizophrenia: Pathology and Treatment.

Kathleen L Benson1.   

Abstract

Both subjective and objective assessments of sleep patterns in schizophrenia include a wide range of dyssomnias, with insomnia being the most frequently cited. Early and middle insomnia can range from mild disruption to total sleeplessness. Severe insomnia is a prodromal sign of clinical exacerbation or relapse. In general, most antipsychotic agents (APs) ameliorate this insomnia. However, in some schizophrenics APs can be associated with residual insomnia or with significant daytime somnolence. Furthermore, in some schizophrenics APs can induce or exacerbate comorbid sleep disorders such as restless legs syndrome, sleep-disordered breathing, and parasomnias such as sleepwalking.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Insomnia; Polysomnography; Schizophrenia; Side effects; Sleep; Sleep disorders

Mesh:

Substances:

Year:  2015        PMID: 26055673     DOI: 10.1016/j.jsmc.2014.11.001

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN: 1556-407X


  13 in total

1.  Sleep onset insomnia, daytime sleepiness and sleep duration in relationship to Toxoplasma gondii IgG seropositivity and serointensity.

Authors:  Zaki Ahmad; Yara W Moustafa; John W Stiller; Mary A Pavlovich; Uttam K Raheja; Claudia Gragnoli; Soren Snitker; Sarra Nazem; Aline Dagdag; Beverly Fang; Dietmar Fuchs; Christopher A Lowry; Teodor T Postolache
Journal:  Pteridines       Date:  2017-11-28       Impact factor: 0.581

2.  Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.

Authors:  Jessica R Lunsford-Avery; Bruno da Silva Brandão Gonçalves; Elisa Brietzke; Rodrigo A Bressan; Ary Gadelha; Randy P Auerbach; Vijay A Mittal
Journal:  Schizophr Res       Date:  2017-02-04       Impact factor: 4.939

3.  Alterations in TRN-anterodorsal thalamocortical circuits affect sleep architecture and homeostatic processes in oxidative stress vulnerable Gclm-/- mice.

Authors:  Christina Czekus; Pascal Steullet; Albert Orero López; Ivan Bozic; Thomas Rusterholz; Mojtaba Bandarabadi; Kim Q Do; Carolina Gutierrez Herrera
Journal:  Mol Psychiatry       Date:  2022-07-28       Impact factor: 13.437

4.  Covering the Gap Between Sleep and Cognition - Mechanisms and Clinical Examples.

Authors:  Javier Gomez-Pilar; Gonzalo C Gutiérrez-Tobal; Roberto Hornero
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

5.  Sleep quality impairments in schizophrenia and bipolar affective disorder patients continue during periods of remission: a case-controlled study.

Authors:  Yunus Hacimusalar; Ozgul Karaaslan; Emre Misir; Ozge Ceren Amuk; Goknur Hacimusalar
Journal:  Sleep Sci       Date:  2022 Jan-Mar

Review 6.  Reduced Sleep Spindles in Schizophrenia: A Treatable Endophenotype That Links Risk Genes to Impaired Cognition?

Authors:  Dara S Manoach; Jen Q Pan; Shaun M Purcell; Robert Stickgold
Journal:  Biol Psychiatry       Date:  2015-10-14       Impact factor: 13.382

Review 7.  Schizophrenia and sleep disorders: links, risks, and management challenges.

Authors:  Rachel E Kaskie; Bianca Graziano; Fabio Ferrarelli
Journal:  Nat Sci Sleep       Date:  2017-09-21

8.  Toxoplasma gondii IgG associations with sleep-wake problems, sleep duration and timing.

Authors:  Celine C Corona; Man Zhang; Abhishek Wadhawan; Melanie L Daue; Maureen W Groer; Aline Dagdag; Christopher A Lowry; Andrew J Hoisington; Kathleen A Ryan; John W Stiller; Dietmar Fuchs; Braxton D Mitchell; Teodor T Postolache
Journal:  Pteridines       Date:  2019-02-19       Impact factor: 0.581

Review 9.  Circadian rhythm disruption and mental health.

Authors:  William H Walker; James C Walton; A Courtney DeVries; Randy J Nelson
Journal:  Transl Psychiatry       Date:  2020-01-23       Impact factor: 6.222

10.  Sleep, sleep spindles, and cognitive functions in drug-naive patients with first-episode psychosis.

Authors:  Naksidil Torun Yazıhan; Sinan Yetkin
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.